Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab plus methotrexate in active rheumatoid arthritis in Chinese patients
ChiCTR-TRC-10001060Phase 3Completed
- Sponsor
- Peking University People's Hospital
- Start
- Dec 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Infliximab + methotrexate with Placebo + methotrexate (2 arms). Primary endpoint: ACR score. Started Dec 2008; status: completed.
02
Drugs
infliximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ChiCTR-TRC-10001060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10001060.